Our firm is passionate and dedicated towards working tirelessly for our clients.  Our efforts recently gained national recognition via Law360.  Law360 is a popular and trusted online legal news outlet whose subscribers include: the top 100 law firms in the United Sates, corporate legal departments, and major federal and state agencies.  Phillips Law Firm received its recognition for its pursuit of justice in a pharmaceutical related suit involving more than 600 claimants.

The Case of Gloria Herrera et al. v. AstraZeneca Pharmaceuticals LP et al.

As reported by Law360, Lowell W. Finson of Phillips Law Firm is legal counsel for numerous plaintiffs in the above cited action.  The action essentially pertains to the drug Crestor.  Crestor is a prescription drug that belongs to a group of cholesterol –lowering medicines called statins.  The drug was first launched in 2003.  It was created by London based AstraZeneca LP and is distributed by the American company McKesson Corp.  Crestor is the fifth-highest selling drug in the United States and accounted for approximately $2.6 billion in sales for 2013.

Mr. Finson is seeking justice against the pharmaceutical industry on behalf of a group of consumers that believe deception is intertwined with Crestor’s prescription.  In particular, the consumers claim AstraZeneca and McKesson (the defendants in the action) deceived them by hiding test results linking Crestor to diabetes and other diseases.  They allege that studies performed by the defendants show that Crestor is connected with higher risks of kidney damage, cardiomyopathy and heart disease.  The claimants further allege that the defendants conspired to suppress or misrepresent their studies to ensure that doctors would continue to prescribe Crestor to their patients.

The complaint in the matter communicates a story of concern for patient safety.  According to this document:

  • “Defendants well knew that prescribing physicians would not be in a position to know the true risks of Crestor and…would rely upon the misleading information that they promulgated.”
  • “Defendants sold or aided and abetted in the sale of Crestor which was and is defective and unreasonably dangerous.”
  • “Defendants knew or should have known that Crestor was and is hazardous to human health.”

The claimants in this action allege that they would not have used Crestor if they were aware, or had known, about the drug’s numerous health risks.

If you haven’t guessed by now, the pharmaceutical industry is a big deal where a single drug can earn manufacturers and distributors billions of dollars.  For example, McKesson reaped the benefits of pharmaceutical sales of $122 billion in 2012.  As of December of 2011, AstraZeneca had a market capitalization of approximately 39.5 billion British pounds.  This is the tenth largest capitalization of any company with a primary listing on the London Stock Exchange.

More Hard Work on the Horizon

The arduous efforts of Mr. Finson and the Phillips Law Firm in this matter are far from over.  Much more work lays on the horizon; but as always, Mr. Finson and Phillips Law is committed to ensuring the work gets completed.

The above described suit was originally filed in Los Angeles Superior Court last year.  As stated earlier, the entire suit involves over 600 claimants.  All of the individual claims and cases involved nearly twenty judges.  The plaintiffs tried to consolidate these claims so that they could all be tried together before one judge.

In response, the defendants recently tried to remove the suit to federal court.  The defendants’ basis for removal is not truly understood and their basis is not compellingly supported by existing law.  The defendants themselves have asked the court not to decide on the removal issue until federal court rules on a somewhat similar case.

Despite this request, however, two judges have already remanded the defendants’ removal efforts back to the Superior Court level.  Time will tell whether or not the defendants withdraw their removal attempts.  In the meantime, Mr. Finson continues to fight against the removal possibility and he marches on in the noble representation of his clients.

This Case is not Unique

The case of Gloria Herrera is not unique to the Phillips Law Firm.  Yes, the facts of every case our firm works with may differ.  However, a solidifying element within all of these cases is the hard work our firm and our attorneys put forth to ensure justice is sought and injuries are remedied.

Our unremitting work ethic is a value that we all honor and seek to uphold.  This is true no matter if a case is against the pharmaceutical industry, a motor vehicle driver, a member of the medical community, or a state agency.  Our attorneys work hard…each day and every day.  They work hard for their clients and they work hard for just results.

by

The Federal Drug Administration has begun an investigation into recent allegations that testosterone drugs and therapies increase the risk of cardiovascular complications. This comes on the heels of a new study published in PLOS One that found an increased risk of heart attacks and strokes in men who were prescribed testosterone therapy. The study showed that men under the age of 65 who had a history of heart disease, as well as men over the age of 65—even those without heart disease—were 2x more likely to suffer a cardiac complication.

This most recent study was not the first study to find a connection between testosterone therapy and heart attacks. Researchers with Veterans Affairs studied 8,700 men between 2005 and 2011 who were undergoing various forms of testosterone therapy. Their results found that men using testosterone drugs were 30% more likely to suffer from heart attacks, strokes, and death.

…But It’s FDA Approved!

The FDA approved testosterone therapies only for men that suffered from low-testosterone due to a medical condition, such as hypogonadism. This medical condition results in the body not producing enough testosterone and men can exhibit signs of fatigue, decreased sex drive, and difficulty concentrating.

Yet the drug has been used to treat men who simply exhibit these symptoms—and not those who have been properly tested. Men’s testosterone levels naturally decline as a result of aging and testosterone therapy is not recommended for these men.

“We’re giving people hormones that we don’t know they need, for a disease that we don’t know they have, and we don’t know if it’ll help them or harm them.”

Dr. Lisa Schwartz, a professor at the Dartmouth Institute for Health Policy and Clinical Practice

The Risk of Heart Attack is Being Ignored

Unfortunately, drug manufacturers have been aggressively marketing their testosterone therapy drugs, and between 2001 and 2011, the use of hormones among men increased by 40%. These companies have not specifically addressed heart attack concerns and stroke warnings on testosterone therapy labels. As a result, more men are beginning to experience serious heart conditions.

If you or someone you love has suffered a heart attack, stroke, or serious heart complication after using a testosterone-enhancing drug, it is important to speak to an experienced testosterone lawsuit attorney immediately.

Filing a Low Testosterone Lawsuit

Men who have experienced adverse side effects, heart attacks, strokes, or even death after using a testosterone-enhancing drug may be able to file a lawsuit. The lawyers at Phillips Law Firm have represented countless families across the country in their quest for justice. If you are interested in learning more about your legal options, call us at 1-800-708-6000. Our low testosterone lawsuit attorneys are waiting to assist you 24/7, offering a free case evaluation. Remember our no fee promise. If we do not recover anything for you, you do not owe us an attorney fee.

by

Testosterone enhancing drugs are facing intense scrutiny after claims of heart attacks and strokes have increased. The FDA has already begun an investigation into the heart and stroke dangers of testosterone enhancing drugs after two recent studies raised concerns.

In November 2013, the Journal of the American Medical Association found that when men without a history of heart disease used testosterone drugs, their risk of death from heart attack or stroke increased by 29%. A separate study also found that men with a history of heart disease were also at an increased risk.

AndroGel Users File Suit

Now 5 men who allege that they suffered heart attacks or strokes after using AndroGel have filed separate lawsuits against Abbott Laboratories and their spinoff AbbVie. In particular, three of the five men suffered heart attacks, one suffered a stroke, and one suffered a mini-stroke after using the ‘Low T’ drug AndroGel.

In addition to causing heart attacks and strokes, testosterone-enhancing drugs have also been known to cause enlarged prostates, enlarged breasts, sleep apnea, and blood clots.

These Drugs Are Unnecessary For Most

Even more concerning is the fact that the majority of men do not even need these drugs. A gradual decline in testosterone is a part of the aging process—it is a fact of life. Yet these testosterone-enhancing drugs have only been approved for treating medical conditions, such as the failure of the testicles to produce testosterone due to genetic issues or as a side effect of chemotherapy. Being used to simply treat low testosterone levels has not been approved.

Yet even with multiple warnings and increased scrutiny, low-T drugs are on the rise. IMS Health said that sales of their testosterone drugs grew by 90% over the past 5 years and reached $1.9 billion in sales in 2011 alone. AndroGel itself reported $1.15 billion in 2012 sales and is now AbbVie’s second best-selling drug. Experts estimate that by 2017, the testosterone market will hit $5 billion.

Contact National Dangerous Drug Attorneys

Men who have experienced adverse side effects, heart attacks, or strokes after using a testosterone-enhancing drug may be able to file a lawsuit. Our experienced defective drug lawyers have represented families across the country in their quest for justice. If you are interested in learning more about your legal options, call us at 1-800-708-6000. Our AndroGel lawsuit attorneys are waiting to assist you 24/7, offering a free case evaluation. Remember our no fee promise. If we do not recover anything for you, you do not owe us an attorney fee.

by

AndroGel Low Testosterone TreatmentLow testosterone drugs have exploded onto the market in recent years, promising aging men a renewed interest in everything from sex to life. Pervasive marketing campaigns warn that low testosterone can interfere with sex drives, moods, and even energy levels. This in turn prompted annual prescriptions for Low-T drugs to increase five fold from 2000 to 2011. In fact, sales totaled nearly $2 billion in 2012 from 5.3 million prescriptions thanks to global ad campaigns.

The Dark Side Of Low Testosterone Treatments

Yet there is a dark side to Low-T drugs. In the first 3 months after starting low testosterone therapy, men younger than 65 who had a history of heart disease were 2x more likely to experience a heart attack or stroke. For men over the age of 65, their risk of heart attacks and strokes increased 2x—even without a history of heart disease.

The latest study to confirm these findings is particularly interesting because it involved a large population, unlike previous studies. The researchers reviewed the records of 55,593 men who had been prescribed testosterone treatments, including over 48,000 records from men that were younger than 65 years old. Specifically, they compared patients who were given testosterone treatments, including Axiron and Androderm with those patients who were simply given Viagra or Cialis. The testosterone group was 2x as likely to suffer a heart attack compared to the impotence pill group. This suggests that the increase in heart complications is due to the treatment prescribed and not merely the sexual behavior.

FDA Intervention is Needed

These results have prompted calls for the FDA to update product labeling and warn consumers of cardiovascular concerns. In addition, physicians and academics have raised concerns that the advertising campaigns of these companies, such as AndroGel, exaggerate both the effectiveness of these drugs and the prevalence of low testosterone among men. A study published in the New England Journal of Medicine in 2010 found that only 2% of men between the ages of 40 and 80 actually suffered from Low T.

Contact National Dangerous Drug Attorneys

Men who have experienced adverse side effects, heart attacks, or strokes after using a testosterone-enhancing drug may be able to file a lawsuit. Our experienced dangerous drug lawyers have represented families across the country in their quest for justice. If you are interested in learning more about your legal options, call us at 1-800-708-6000. Our low testosterone lawsuit attorneys are waiting to assist you 24/7, offering a free case evaluation. Remember our no fee promise. If we do not recover anything for you, you do not owe us an attorney fee.

by

Consumer advocates are applauding the FDA’s recent announcement to allow generic drug manufacturers to make changes to safety labels.

Currently, brand name manufacturers are allowed to change their labels, without FDA approval, if the company becomes aware of new risks associated with the drug after some time on the market. Generic drug companies are only allowed to change product safety labeling if it were ordered to do so by the FDA or if its brand name equivalent made a similar change. However, there are 434 generic drugs on the market with no brand name equivalent, according to the consumer advocacy group, Public Citizen.

Consumer watchdog groups and medical experts have been petitioning for years for a revision of FDA rules because generic drugs have become so popular in the last few decades. Over 80% of prescriptions last year were filled with generic drugs. Dr. Sydney Wolfe of Public Citizen’s health research group says, “The proposed rule…will provide added protection to the tens of millions of people who regularly use generic drugs.”

Multiple lawsuits against generic drug manufacturers have been dismissed since 2011, when the Supreme Court ruled that inadequate labeling of a generic drug was not cause for a lawsuit against the maker. In contrast, a name brand drug is liable for inadequate safety labels. Experts say this causes a “regulatory gap” between generic and name brand product safety.

Michael Johnson, a lawyer who represented one of the patients who sued generic drug companies in the 2011 Supreme Court case, Pliva v. Mensing, says that the proposition “is a first step toward acknowledging that there is a problem with the current system. It doesn’t make sense to have one set of rules for the name brand and another set for the generics.”

The FDA says that the proposed change would create equality between generic and name brand manufacturers in respect to updating their drug safety labels. Because the proposition would allow generic manufacturers to change their labels if they became aware of safety issues, it could also make them liable for potential harm to patients.

In the past, generic drug companies have been opposed to such a change, saying that they prefer to leave decisions about drug safety in the hands of the FDA. The FDA is expected to publish a proposed rule by September.

If you or someone you love was injured after taking a dangerous and defective drug, it is important to contact an experienced dangerous drug lawsuit attorney immediately. The Phillips Law Firm can assist you with all of your legal needs. Our national dangerous drug lawsuit attorneys will provide you with a free case evaluation and help you determine your rights to compensation for your injuries. Call us at 1-800-708-6000today to schedule your appointment.

by

Rebecca Richard has filed a Byetta lawsuit in U.S. District Court for the Southern District of California on behalf of her deceased husband’s estate. The lawsuit, filed on June 28, 2013, alleges that David Richard developed terminal pancreatic cancer as a direct and proximate use of the diabetes medication, Byetta. Listed as defendants in the complaint are Amylin Pharmaceuticals and Eli Lilly, the drug’s manufacturers. Court documents state that the deceased was prescribed Byetta on July 27, 2005. He continued taking the medication through May 2010, and sought emergency medical attention in April 2011, after experiencing intense abdominal pain. Shortly after, he was diagnosed with advanced pancreatic cancer, which led to his untimely death on July 27, 2011.

His widow alleges that the defendants failed to adequately warn patients and health care providers of the risks of pancreatic cancer associated with Byetta, and neglected to caution physicians to monitor for the first signs of changes in the pancreas. Byetta, a member of a new class of drugs called incretin mimetics (GPL-1), was approved by the FDA in 2005 to help stabilize blood glucose levels and prevent complications in patients with Type 2 diabetes.

By 2010, however, concerns were published regarding a potential link with pancreatic cancer and Byetta and DDP-4 inhibitors, including Januvia. Researchers in the medical journal Diabetes Care, wrote, “We feel that enough preliminary evidence has accumulated to suggest that there is a plausible risk that long-term recipients of GLP-1-based therapy may develop asymptomatic chronic pancreatitis (Fig. 1), and worse, subsequently a minority of individuals treated by this class of drug may develop pancreatic cancer.”

In 2011, additional research on Byetta side effects was published in the online journal Gastroenterology, showing that patients treated with Byetta had a 2.9 time greater risk of developing pancreatic cancer as patients treated with other drugs.

The FDA announced on March 14, that it discovered evidence of pre-cancerous cell changes in pancreatic tissue samples of patients who had taken Byetta, Januvia or other incretin mimetics. The agency is to investigate further.

Prior clinical studies indicate an increased risk of pancreatitis; a condition associated with higher instances of pancreatic cancer, with GLP-1 based therapies such as Byetta.

The plaintiff is seeking damages alleging failure to warn, design defect, negligence, breach of implied and expressed warranty, negligent misrepresentation, fraudulent concealment, and loss of consortium.

Patients who have been injured after using the diabetic Byetta may be able to file a lawsuit. To learn more about your rights and legal options, call the Phillips Law Firm today. Our experienced Byetta lawsuit lawyers have represented families across the country in their quest for justice. For a free consultation visit the Phillips Law Firm website http://www.justiceforyou.com or call 1-800-708-6000.

by

As part of the early discovery process, select Zoloft birth defect cases will be the first trials to be heard in court. The outcome of these bellwether trials, set to begin on October 13, 2014, will potentially set a precedent for the remaining cases. However, the involved parties are in disagreement over how the Zoloft lawsuits should be chosen.

Zoloft (sertraline) was approved by the FDA in 1992 to treat depression and is currently one of the most widely prescribed SSRI anti-depressants in the country. Zoloft has been prescribed to tens of millions of people, however the FDA raised concerns about its safety in November 2006 when the agency added a warning that women were at a six times greater risk of persistent pulmonary hypertension in newborns if they took the drug after 20 weeks of pregnancy.

A link between a risk of brain defects and gastrointestinal abnormalities and the use of anti-depressants, such as Zoloft, in early pregnancy was reported in June 2007. A September 2009 study published in the British Medical Journal found that the risk of heart defects increased when Zoloft was taken in the first trimester.

The plaintiffs allege that they were not adequately informed of potential risks, and that the drug manufacturer, Pfizer, was negligent in producing and marketing an unsafe drug. Some of the deformities alleged by plaintiffs include holes in the heart, clubfeet, spina bifida, skull defects, cleft palates and persistent pulmonary hypertension. However, all of the Zoloft birth defect lawsuit filings share similar claims-that, when taken during pregnancy, the anti-depressant caused fetal malformations.

To better handle litigation, the 430 similar Zoloft lawsuits were consolidated into a multidistrict litigation and centralized in the Eastern District of Pennsylvania in April 2012 and are presided over by U.S. District Judge Cynthia Rufe.

Pfizer and plaintiff attorneys have agreed that the 25 cases in the “Initial Discovery Pool” should be narrowed down to 13 cases chosen by Pfizer and 12 cases chosen by leadership-appointed plaintiff attorneys. Both parties also agree that the “Trial Pool” should consist of six cases, three chosen by each side.

However, Special Discovery Master Andrew A. Chirls recently reported that the parties disagree on how to narrow down the cases. Pfizer wants to select which cases to pursue after the plaintiffs pick their cases. The attorneys feel that in order to be fair, the picks need to be made simultaneously. Furthermore, Pfizer recommends that each side prepare only one case for the October 13, 2014 trial date in order to save money. Meanwhile, the attorneys for the plaintiffs intend to prepare all selected Trial Pool cases at once. In the meantime, the Discovery Master is allowing the parties to disagree until further negotiations can take place.

Zoloft Lawsuit Attorneys

If your baby was born with a birth defect after you took the dangerous drug Zoloft during pregnancy, it is important to know that you are not alone. The national Zoloft lawsuit attorneys at Phillips Law Firm can help. We represent patients across the United States who have been injured or hurt after taking a dangerous drug. If you are interested in learning more about your legal options, call us at 1-800-708-6000. Our Zoloft lawsuit attorneys are waiting to assist you 24/7, offering a free case evaluation. Remember our no fee promise. If we do not recover anything for you, you do not owe us an attorney fee.

by

The makers of Tylenol will soon be debuting new red warnings on all bottles of the product sold in the U.S. Johnson & Johnson took the unusual step under pressure from the government amid a growing number of lawsuits involving overdoses.

The new warning will appear in October on the cap of every bottle of Extra Strength Tylenol and on most other Tylenol bottles within the coming months. It is designed to get the attention of people who do not read the warnings that are located in the fine print of the product’s label. The warning will make it clear that Tylenol contains acetaminophen, a pain-relieving agent that is the nation’s leading cause of liver failure, and one that is taken by millions of people every day.

55,000 to 80,000 people are treated in the emergency room every year for acetaminophen overdoses, and 500 of those will die, according to the Centers for Disease Control.

The new cap message will read: “CONTAINS ACETAMINOPHEN, ALWAYS READ THE LABEL”. Research into the misuse of Tylenol has resulted in the product becoming the first of the more than 600 over-the –counter products containing acetaminophen, to bear such a warning label.

Presently, there are more than 85 personal injury lawsuits in federal court alleging that Tylenol is responsible for liver injuries and deaths.

Much is at stake for a company that reported $1.75 billion in sales last year of acetaminophen-based products as the FDA drafts long-awaited safety measures that could curtail the use of Tylenol and other such products.

Most experts agree that acetaminophen is safe when used as directed; however, safety experts are concerned about “extra strength” doses of acetaminophen making it easy to exceed the 4,000 milligram/day recommended dosage.

Johnson & Johnson parent company, McNeil, has updated safety warnings on the product periodically over the years, and has voluntarily adopted changes recommended by FDA-assembled expert panels, but has not embraced the FDA’s recommendation to eliminate Extra Strength Tylenol altogether.

Acetaminophen overdoses occur when the liver is overwhelmed by too much of the drug, producing a toxic byproduct and killing liver cells. When most cells are no longer able to function, liver failure occurs and most patients have 24-48 hours to live without a liver transplant.

About half of the 500 annual acetaminophen deaths are considered accidental. Still, there are cases of liver damage in patients who have stayed well within the 4,000mg/day safety threshold.

These lawsuits alleging that the company risked lives by making “conscious decisions not to redesign, re-label, warn or inform the unsuspecting consuming public” have been consolidated under a single federal judge in the Eastern District of Pennsylvania near McNeil’s headquarters in Ft. Washington, PA.

Tylenol Lawsuit Attorneys

If you or someone you love has had liver damage or liver failure after taking Tylenol, it is important to know your legal options. The national Tylenol lawsuit attorneys at Phillips Law Firm can help. We represent patients across the United States who have been injured or hurt after taking a dangerous drug. If you are interested in learning more about your legal options, call us at 1-800-708-6000. We are waiting to assist you 24/7, offering a free case evaluation. Remember our no fee promise. If we do not recover anything for you, you do not owe us an attorney fee.

by

Zoloft Pregnancy Side Effects

Categories:

On June 28, 2013, a new Zoloft side effects lawsuit was filed in the U.S. District Court for the Eastern District of Pennsylvania. A Florida woman has filed the lawsuit against Phizer, Zoloft’s manufacturer, alleging that side effects from the drug caused her baby to be born with congenital birth defects. The U.S. Judicial Panel recently consolidated the increasing number of Zoloft birth defects lawsuits into a multidistrict litigation (MDL). An MDL encourages the parties to settle all their disputes at once, and helps to eliminate conflicting rulings from multiple forums.

Zoloft heart defects lawsuit facts and allegations

On September 11, 2006, the plaintiff gave birth to her baby with severe heart defects. Among other heart defects, doctors diagnosed the baby with Patent Foramen Ovale (PFO) and Patent Ductus Arteriosus (PDA), most commonly referred to as “holes in the heart.” While it is normal for there to be small openings between the heart’s left and right upper chambers and between certain blood vessels in the heart during fetal development, these openings did not close properly. If left untreated, the baby could experience strokes, heart failure and other serious heart defects. It is not uncommon for pregnant women to be prescribed sertraline, the chemical name for Zoloft. Yet as early as 1996, just five years after the FDA approved Zoloft, researchers discovered a link between selective serotonin reuptake inhibitor (SSRI) antidepressants and various congenital heart defects. A 2006 study in the New England Journal of Medicine and a 2009 Danish study confirmed these findings. The various lawsuits filed allege that Phizer has consistently refused to acknowledge the possibility of a link between Zoloft and heart defects. While there is a generic warning in the drug packaging that pregnant women “should not take Zoloft before consulting their physician”, it mentions nothing about the known link between Zoloft and birth defects. The plaintiff is seeking unspecified damages for medical bills, loss of consortium and punitive damages. She alleges that Phizer knowingly committed various wrongful acts, including failure to warn, design defect, negligence and fraud. Phizer continues to adamantly defend the safety of its SSRI antidepressant, Zoloft, even in the face of mounting lawsuits and adverse evidence.

Zoloft Lawsuit Attorneys

If you or someone you love has taken Zoloft during pregnancy and given birth to a baby with heart defects or congenital defects, we can help. The national Zoloft lawsuit attorneys at Phillips Law Firm represent injured patients across the United States. We are not afraid to fight the large pharmaceutical companies and medical corporations who continue to put profits before patient safety. If you are interested in learning more about your legal options, call us at 1-800-708-6000. Our Zoloft lawsuit attorneys are waiting to assist you 24/7, offering a free case evaluation. Remember our no fee promise. If we do not recover anything for you, you do not owe us an attorney fee.

by

In-utero exposure to selective serotonin reuptake inhibitors (SSRIs) has been “associated with an increased risk of autism spectrum disorders, particularly without intellectual disability”, according to a Swedish study conducted this spring. Other research had previously indicated a correlation between a mother’s use of these drugs during pregnancy and birth defects and a serious lung condition found in newborns. According to the U.S. Food and Drug Administration, drugs in the class of SRRIs include, Paxil, Celaxa, Lexapro, Prozac, Luvox, Viibryd and Zoloft (sertraline hydrochloride). Researchers in the U.K. documented the autism study and published the findings in the April 19 edition of the British Medical Journal. However, experts at the University of Bristol associated with the study admit that their observations in Sweden warrant further study. Zoloft, a Phizer product, was approved in 1991. At that time, physicians lacked the knowledge to be able to warn their female patients so that they could have avoided the risk of persistent pulmonary hypertension of the newborn (PPHN). New information about the increased risk of PPHN did not surface until about seven years ago. While more research on the autism connection waits, Zoloft’s label does warn of its apparent risk of lung disease by stating: “Infants exposed to SSRIs in pregnancy may have an increased risk for persistent pulmonary hypertension of the newborn (PPHN) [which] is associated with substantial neonatal morbidity and mortality.” The FDA says that, babies suffering from PPHN “have high pressures in their lung blood vessels and are not able to get enough oxygen into their bloodstream.” And now, as if the PPHN risk was not enough, a researcher based in Helsinki, published a study in December showing a link with Zoloft and increased risk of newborn “omphalocele, anal atresia, limb-reduction defects, cardiac septal defects and anencephaly.” Many class action lawsuits for Zoloft and similar SSRI-related actions have been filed and more are expected to be filed.

Zoloft Lawsuit Attorneys

If your child was diagnosed with autism and you took the dangerous drug Zoloft during your pregnancy, it is important to speak with a Zoloft lawsuit attorney immediately. The national Zoloft lawsuit attorneys at Phillips Law Firm can help. If you are interested in learning more about your legal options, call us at 1-800-708-6000. Our national Zoloft lawsuit attorneys are waiting to assist you 24/7, offering a free case evaluation. Remember our no fee promise. If we do not recover anything for you, you do not owe us an attorney fee.

by